The outbreak had a big head start, and we're still behind.
In the eastern provinces of Congo, a rare strain of Ebola called Bundibugyo moves through communities faster than the systems meant to stop it. Since mid-May, 344 people have tested positive and 60 have died across Ituri, North Kivu, and South Kivu — a region long fractured by armed conflict, displacement, and eroded institutional trust. The World Health Organization has acknowledged plainly that the outbreak had a head start, and the work of catching up unfolds against a landscape where science, security, and human cooperation must all align at once.
- The Bundibugyo strain — with no approved vaccine or treatment — has confirmed 344 cases and 60 deaths since mid-May, and the WHO's own director-general admits the response is still running behind.
- Contact tracing, the backbone of outbreak containment, has reached only 45% of known contacts — less than half the 90% threshold health officials say is needed to actually get ahead of the virus.
- Armed factions including M23 and the Allied Democratic Forces control parts of the affected region, displacing hundreds of thousands and making entire populations nearly impossible to locate or monitor.
- Community mistrust has turned health workers into targets — residents in some areas have attacked clinics and refused to believe the outbreak is real, keeping sick people from seeking care.
- Testing improvements have reduced suspected cases from 906 to 116, offering a narrow sign of progress, but Doctors Without Borders warns the true scale of the outbreak remains unknown given how much of the region remains unreachable.
Since mid-May, a rare Ebola strain called Bundibugyo has spread through three eastern Congolese provinces — Ituri, North Kivu, and South Kivu — confirming 344 cases and killing 60 people. Unlike more familiar strains, Bundibugyo has no approved vaccine or treatment. On Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus offered a candid assessment: the outbreak had a significant head start, and the response is still catching up.
There are modest signs of progress. Improved lab capacity has driven suspected cases down sharply, from 906 to 116, as testing separates confirmed infections from false alarms. At least five people have recovered. Neighboring Uganda has reported 15 cases and one death. But the gap between where the response is and where it needs to be remains wide.
The sharpest bottleneck is contact tracing — the labor-intensive process of identifying and monitoring everyone exposed to an infected person. Only 45% of contacts have been followed up, far short of the 90% threshold needed to contain the virus. The reasons are structural and severe: armed groups including the M23 rebel faction and the Islamic State-aligned Allied Democratic Forces control parts of the region, and years of conflict have displaced hundreds of thousands of people who move constantly and are difficult to find.
Community resistance compounds the challenge. In some areas, residents have attacked health centers and rejected the reality of the outbreak altogether, keeping symptomatic people from seeking care. Health workers operate under both physical threat and deep suspicion in a region where trust in institutions has been worn away over decades.
Doctors Without Borders cautioned that the outbreak's true scale remains unclear, given how much of the affected territory is still unreachable. A Congolese epidemiologist who has managed previous outbreaks warned that developing and deploying a vaccine could take months — if the scientific and logistical obstacles can be cleared at all. For now, the path forward runs through better labs, higher contact tracing rates, and the slow, uncertain work of rebuilding enough trust that people will seek help before it is too late.
The Ebola outbreak spreading through eastern Congo has moved faster than the response meant to contain it. Since mid-May, when the virus was first confirmed in the provinces of Ituri, North Kivu, and South Kivu, 344 people have tested positive and 60 have died. The virus is a rare strain called Bundibugyo, one without an approved vaccine or treatment. On Wednesday, the World Health Organization's director-general, Tedros Adhanom Ghebreyesus, acknowledged the hard truth: the outbreak "had a big head start, and we're still behind."
But there are small signs of progress. Testing capacity has improved enough that suspected cases have dropped sharply—from 906 down to 116 as labs confirm which patients actually carry the virus and which do not. At least five people have recovered, a rare glimmer in an otherwise grim picture. Neighboring Uganda has reported 15 confirmed cases and one death. The WHO chief said the organization is "catching up," though the gap remains wide.
The real bottleneck is contact tracing—the painstaking work of finding everyone who has been near an infected person and monitoring them for symptoms. Only 45 percent of contacts have been tracked and followed up so far. To actually get ahead of the outbreak, health officials say that number needs to climb above 90 percent. That gap reflects the chaos on the ground. Armed groups control parts of the region, including the M23 rebel faction backed by Rwanda, which seized the cities of Goma and Bukavu more than a year ago. The Allied Democratic Forces, an Islamic State-aligned militia, operates in the border zone between Congo and Uganda. Years of conflict have displaced hundreds of thousands of people, creating populations that move constantly and are nearly impossible to locate.
Community resistance has made the work harder still. Residents in some areas have attacked health centers, at times demanding the bodies of their dead. Some people do not believe Ebola is real, which keeps them from seeking care even when they show symptoms. Health workers have become targets of both violence and suspicion in a region where trust in institutions has been shattered by decades of instability.
Doctors Without Borders cautioned Monday that the true scale of the outbreak remains unclear. The testing capacity, while improving, is still extremely limited, and armed groups and insecurity make it difficult to reach certain areas. A Congolese epidemiologist named Aruna Abedi, who has managed previous Ebola outbreaks in the country, told the Associated Press that developing and deploying a vaccine could take months—a timeline that assumes the scientific and logistical hurdles can be cleared at all.
The WHO chief sidestepped a question about a U.S. quarantine facility in Kenya that has drawn local protests, saying only that the United States had made its own risk assessment and could do as it saw fit. For now, the focus remains on the ground in Congo: improving lab capacity, pushing contact tracing higher, and trying to rebuild enough trust that people will seek help when they fall ill. The outbreak has a head start. Catching up will require speed, resources, and a region willing to cooperate—none of which are guaranteed.
Notable Quotes
The outbreak had a big head start, and we're still behind, but we are catching up as testing improves.— Tedros Adhanom Ghebreyesus, WHO Director-General
Only about 45 percent of contacts have been followed up, and to get ahead of the outbreak we need to get that number up to above 90 percent.— Tedros Adhanom Ghebreyesus, WHO Director-General
The Hearth Conversation Another angle on the story
Why is contact tracing only at 45 percent when it's so critical to stopping the spread?
Because the people you're trying to trace are either displaced by armed conflict, moving constantly, or living in areas controlled by rebel groups. You can't follow up with someone if you can't reach them or if they don't trust you enough to let you in.
And the community resistance—is that just fear, or something deeper?
It's both. People have seen health systems fail them for decades. Some genuinely don't believe Ebola is real because the virus is rare and the messaging hasn't landed. Others have watched armed groups and government forces use health clinics as cover for violence. When you attack a health center demanding your dead back, you're not just grieving—you're expressing a deeper loss of faith.
The WHO says they're catching up. Does that feel true from what you're seeing?
Testing is genuinely improving, which matters. But catching up and getting ahead are different things. You catch up when you're reducing cases. You get ahead when you're preventing them. Right now they're still in the catching-up phase, and the contact tracing numbers show it.
What about the vaccine timeline—months away?
Months is optimistic. It assumes the scientific work is done, the supply chains hold, and you can actually deliver doses to three provinces in active conflict zones. That's not a medical problem anymore. That's a logistics and security problem.
So what has to happen for this to turn?
The insecurity has to stabilize enough that health workers can move freely. Communities have to see that seeking care actually helps people survive. And contact tracing has to become fast enough that you're catching cases before they spread. Right now, none of those things are guaranteed.